Hostname: page-component-745bb68f8f-kw2vx Total loading time: 0 Render date: 2025-02-06T10:23:36.819Z Has data issue: false hasContentIssue false

Use of terbutaline in the treatment of complete heart block in the fetus

Published online by Cambridge University Press:  15 August 2006

Blair V. Robinson
Affiliation:
University of North Carolina at Chapel Hill, NC, USA
José A. Ettedgui
Affiliation:
Children's Hospital of Pittsburgh, Pittsburgh, USA
Frederick S. Sherman
Affiliation:
Magee-Women's Hospital, Pittsburgh, PA, USA
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Between 1989 and 2000, 21 fetuses were diagnosed with complete atrioventricular block. Seven women with fetal ventricular rates of less than 60 were given oral terbutaline, and 6 of these had an initial increase in the fetal ventricular rate. Four fetuses (57%) maintained an increased average rate of 60 beats per minute and survived. Two fetuses returned to rates below 55 and died. The final fetus, with hypertrophic cardiomyopathy, was unresponsive. Terbutaline, therefore, is initially effective in raising the fetal ventricular rate, but this effect may be transient.

Type
Brief Report
Copyright
2001 Cambridge University Press